ASTCT Pharmacy SIG Online Journal Club - September 2021

ASTCT Pharmacy SIG Journal Club Session – September 9, 2021

Presenters & Articles

Rebecca Rezac, PharmD
PGY2 Oncology Resident
UCHealth
rebecca.rezac@uchealth.org

Safety and Tolerability of SARS-CoV2 Emergency-Use Authorized Vaccines for Allogeneic Hematopoietic Stem Cell Transplant Recipients 

Emily Ketchum, PharmD
PGY-2 Oncology Pharmacy Resident
Augusta University Medical Center
eketchum@augusta.edu

Belumosudil for Chronic Graft-versus-Host Disease (cGVHD) After 2 or More Prior Lines of Therapy: The ROCKstar Study

Session Learning Objectives:
Upon completion of the activity, participants should be able to:

1. Discuss recent BMT pharmacy studies and their applications to current practice.
2. Identify efficacy of SARS-CoV-2 vaccination and vaccine adverse events in patients receiving vaccination for SARS-CoV-2 following allogeneic hematopoietic stem cell transplant.
3. Describe the evidence supporting belumosudil for chronic graft-versus-host disease (cGVHD) and identify the current place in therapy and clinical implications of belumosudil.  

For full CE information, including presenter disclosures, and accreditation information, please click here to view and download the CE handout.

This activity is jointly provided by The France Foundation and ASTCT. The France Foundation is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education and will award 1.0 CEU to pharmacists who complete the activity, complete the registration and evaluation forms, and successfully pass a post-test (>75%).

Key:

Complete
Failed
Available
Locked
ASTCT Pharmacy SIG Online Journal Club - September 2021 Recording
Open to view video.
Open to view video.